The Efficacy of Adding Dexmedetomidine Perineurally to Bupivacaine in Ultrasound Guided Fascia Iliaca Block Versus Intravenously Infused Dexmedetomidine on Hemodynamic Stability Intraoperatively and Postoperative Analgesia Following Hip Arthroscopy

• Status: Recruiting
• Trial end date: 2021-08-31
• Target enrollment: 0
• Participant gender: All

Summary

The current study aims to assess effectiveness of dexmedetomidine as adjuvant to general anesthesia on the hemodynamic stability and narcotic consumption intraoperatively and its effect as adjuvant to fascia iliaca compartment block (FICB) with bupivacaine on the postoperative analgesia following hip arthroscopy (decrease the need to narcotics postoperatively avoiding their complications and increasing the success rate of surgery, by enhancing patients to move easier).

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ain Shams University
• Treatments: Bupivacaine; Dexmedetomidine

Criteria

Inclusion Criteria:

• Patients undergoing elective hip arthroscopy.

• ASA I and II patients

• aged 18 to 65 years,

• 70-80 kg,

• both sexes.

• Exclusion Criteria:

• Refusal of the patient to receive FICB or to participate in the study,

• Impaired renal or hepatic functions,

• Asthmatic patients.

• Patients with multiple traumas.

• Obese patients with Body Mass Index > 35.

• Allergy to study drugs.

• Patients with local infection.

• Previous surgery at the injection area.

• Bleeding disorders.

• Patients on anticoagulant therapy,

• Addicts.

• Patients with an opioid analgesic prescription within the last 2 h before the operation.

• Peripheral neuropathy,

• Mental and or psychiatric disorders.